Latest Administration News

Paladin Energy has launched a fully underwritten A$300 million equity raising to advance its Patterson Lake South uranium project, aiming for a Final Investment Decision and first production by 2031.

New Hope Corporation Limited has unveiled a Dividend Reinvestment Plan (DRP) offering eligible Australian and New Zealand shareholders a flexible, fee-free way to reinvest dividends into additional shares. The plan empowers investors to grow their holdings conveniently while maintaining control over participation levels.

CSL Limited has partnered with Dutch biotech VarmX to develop VMX-C001, a novel treatment aimed at reversing bleeding in patients on FXa inhibitors, with FDA Fast Track status and a potential 2029 launch.

Washington H. Soul Pattinson has released comprehensive rules for its Dividend Reinvestment Plan, clarifying shareholder eligibility, participation options, and share allocation procedures.

Blue Energy Limited has addressed ASX concerns over the timing of its Cleansing Notice related to the grant of Production Licence PL 1034 for its Sapphire gas project, confirming compliance with disclosure rules despite delayed formal notification.

Celsius Resources has reported significant high-grade copper and gold drilling results at its MCB Project in the Philippines, alongside securing a conditional water permit crucial for advancing project development.

Cleo Diagnostics has received encouraging feedback from the U.S. FDA on its ovarian cancer pre-surgical triage test, reinforcing its clinical trial design and regulatory strategy ahead of a critical 510(k) submission.

TMK Energy Limited’s securities have been suspended from ASX trading due to a missed periodic report deadline, raising questions about the company’s regulatory adherence and market outlook.

Actinogen Medical has reached a pivotal agreement with the US FDA outlining the regulatory and clinical trial requirements for Xanamem’s approval in Alzheimer’s disease, setting a clear path toward a US marketing application.

Medicare contractor Novitas plans to convene an expert panel in early 2026 to review coverage for Pacific Edge’s Cxbladder Triage test following the 2025 update to the American Urological Association microhematuria guideline.

OZZ Resources Limited has provided a detailed update to ASX on its prolonged voluntary suspension, citing procedural delays in Zimbabwe and a pending joint venture at its Maguires Reward Project. The company outlines exploration activities, expenditure, and plans to resume trading.

Botala Energy has disclosed an inadvertent breach of ASX Listing Rule 10.11 involving the issuance of shares to a related party without shareholder approval, and is taking corrective steps to resolve the issue.